FMXIN002 in Patients at Risk of Anaphylaxis

Clinical trial NCT07045701 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07045701
Sponsor: Nasus Pharma
Status: ENROLLING_BY_INVITATION
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Anaphylaxis Food

Start date: 2025-06-12
Primary completion: 2026-06-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.